How effective is Risperdal for Paranoia? (by duration, gender, age)

Summary:

Overall ratings: 2.4/5
Long term ratings: 3/5

This is a phase IV clinical study of how effective Risperdal (risperidone) is for Paranoia and for what kind of people. The study is created by eHealthMe from 5 Risperdal users and is updated continuously.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.


On Nov, 30, 2022

5 people are studied for taking Risperdal in Paranoia


What is Risperdal?

Risperdal has active ingredients of risperidone. It is often used in bipolar disorder. eHealthMe is studying from 120,561 Risperdal users for its effectiveness, alternative drugs and more.

What is Paranoia?

Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur) is found to be associated with 1,790 drugs and 1,264 conditions by eHealthMe.

Overall effectiveness (number of people):

Does Risperdal work for your Paranoia (overall)?

Long term (1+ years) effectiveness (number of people):

Does Risperdal work for your Paranoia (long term)?

Risperdal effectiveness for Paranoia (number of people):

Overall:
  • not at all: 1
  • somewhat: 2
  • moderate: 1
  • high: 1
  • very high: 0
Long Term:
  • not at all: 0
  • somewhat: 1
  • moderate: 0
  • high: 1
  • very high: 0

Gender of people who take Risperdal for Paranoia *:

  • female: 40 %
  • male: 60 %

Age of people who take Risperdal for Paranoia *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 60 %
  • 30-39: 20 %
  • 40-49: 0.0 %
  • 50-59: 20 %
  • 60+: 0.0 %

Who find Risperdal more effective for Paranoia?

Gender of people who take Risperdal for Paranoia *:

  • female: 100 %
  • male: 0.0 %

Age of people who take Risperdal for Paranoia *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 100 %
  • 60+: 0.0 %

* Approximation only. Some reports may have incomplete information.

Do you take Risperdal?

- You can start a phase IV clinical trial to monitor Risperdal safety and effectiveness.

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of:

Treatments, associated drugs and conditions:

How the study uses the data?

The study is based on risperidone (the active ingredients of Risperdal) and Risperdal (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: